{"entity":{"type":"insider","cik":"0001531178","url":"/insider/0001531178","json_url":"/insider/0001531178.json","name":"Edick Paul R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":15,"first":"2012-08-16","last":"2023-08-09","span_basis":"filed_date"},"name_variants":[{"name":"Edick Paul R","source":"filing","n_filings":15,"first_seen":"2012-08-16","last_seen":"2023-08-09"}],"transactions":[{"id":8663876,"accession":"0001867096-23-000117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-23-000117","line_url":"/filing/0001867096-23-000117#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.3794,"price_display":"2.38","price_state":"stated","total_value":23794.0,"total_display":"23,794.00","total_whole":"23,794","shares_owned_after":2288064.0,"shares_owned_after_display":"2,288,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-09","scope":"insider"},{"id":6109449,"accession":"0001867096-22-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-22-000131","line_url":"/filing/0001867096-22-000131#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":29000.0,"total_display":"29,000.00","total_whole":"29,000","shares_owned_after":1528064.0,"shares_owned_after_display":"1,528,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-14","scope":"insider"},{"id":6410985,"accession":"0001867096-22-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-22-000067","line_url":"/filing/0001867096-22-000067#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.4038,"price_display":"1.40","price_state":"stated","total_value":140380.0,"total_display":"140,380.00","total_whole":"140,380","shares_owned_after":1508064.0,"shares_owned_after_display":"1,508,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-13","scope":"insider"},{"id":5535297,"accession":"0001867096-21-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-21-000080","line_url":"/filing/0001867096-21-000080#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.2832,"price_display":"2.28","price_state":"stated","total_value":45664.0,"total_display":"45,664.00","total_whole":"45,664","shares_owned_after":33430.0,"shares_owned_after_display":"33,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-16","scope":"insider"},{"id":4751742,"accession":"0001867096-21-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-21-000076","line_url":"/filing/0001867096-21-000076#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":2.0788,"price_display":"2.08","price_state":"stated","total_value":415760.0,"total_display":"415,760.00","total_whole":"415,760","shares_owned_after":808064.0,"shares_owned_after_display":"808,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-12","scope":"insider"},{"id":2260759,"accession":"0001346302-20-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001346302-20-000075","line_url":"/filing/0001346302-20-000075#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.0551,"price_display":"4.06","price_state":"stated","total_value":40551.0,"total_display":"40,551.00","total_whole":"40,551","shares_owned_after":411134.0,"shares_owned_after_display":"411,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-09","filed_date":"2020-12-10","scope":"insider"},{"id":2778109,"accession":"0000899243-20-012590","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-012590","line_url":"/filing/0000899243-20-012590#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33000.0,"shares_display":"33,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":99000.0,"total_display":"99,000.00","total_whole":"99,000","shares_owned_after":401134.0,"shares_owned_after_display":"401,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-11","scope":"insider"},{"id":3275443,"accession":"0000899243-20-004912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-004912","line_url":"/filing/0000899243-20-004912#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":83000.0,"total_display":"83,000.00","total_whole":"83,000","shares_owned_after":183134.0,"shares_owned_after_display":"183,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-18","scope":"insider"},{"id":8091921,"accession":"0000899243-19-028235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028235","line_url":"/filing/0000899243-19-028235#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17935.0,"shares_display":"17,935","price_per_share":8.5466,"price_display":"8.55","price_state":"stated","total_value":153283.271,"total_display":"153,283.27","total_whole":"153,283","shares_owned_after":172935.0,"shares_owned_after_display":"172,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-27","scope":"insider"},{"id":7804549,"accession":"0000899243-19-007350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-007350","line_url":"/filing/0000899243-19-007350#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":9.1195,"price_display":"9.12","price_state":"stated","total_value":273585.0,"total_display":"273,585.00","total_whole":"273,585","shares_owned_after":155000.0,"shares_owned_after_display":"155,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-11","filed_date":"2019-03-12","scope":"insider"},{"id":6000836,"accession":"0001209191-18-048518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-048518","line_url":"/filing/0001209191-18-048518#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":10.4374,"price_display":"10.44","price_state":"stated","total_value":5218.7,"total_display":"5,218.70","total_whole":"5,219","shares_owned_after":25236.0,"shares_owned_after_display":"25,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-27","scope":"insider"},{"id":6972519,"accession":"0001209191-14-041234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-041234","line_url":"/filing/0001209191-14-041234#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":15.23,"price_display":"15.23","price_state":"stated","total_value":45690.0,"total_display":"45,690.00","total_whole":"45,690","shares_owned_after":45636.0,"shares_owned_after_display":"45,636","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-12","filed_date":"2014-06-13","scope":"insider"},{"id":4825426,"accession":"0001181431-13-028959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-028959","line_url":"/filing/0001181431-13-028959#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":7.089,"price_display":"7.09","price_state":"stated","total_value":21267.0,"total_display":"21,267.00","total_whole":"21,267","shares_owned_after":43136.0,"shares_owned_after_display":"43,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-20","filed_date":"2013-05-20","scope":"insider"},{"id":3164530,"accession":"0001181431-12-045996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-045996","line_url":"/filing/0001181431-12-045996#line-1","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":8.65,"price_display":"8.65","price_state":"stated","total_value":43250.0,"total_display":"43,250.00","total_whole":"43,250","shares_owned_after":24636.0,"shares_owned_after_display":"24,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-14","filed_date":"2012-08-16","scope":"insider"},{"id":5251082,"accession":"0001181431-13-009845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-009845","line_url":"/filing/0001181431-13-009845","is_derivative":false,"issuer_cik":"0001531178","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001531178","owner_cik":"0001531178","owner_name":"Edick Paul R","owner_display_name":"Edick Paul R","owner_url":"/insider/0001531178","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15500.0,"shares_display":"15,500","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":139500.0,"total_display":"139,500.00","total_whole":"139,500","shares_owned_after":39636.0,"shares_owned_after_display":"39,636","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-24","filed_date":"2013-02-14","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001867096","name":"Xeris Biopharma Holdings, Inc.","url":"/issuer/0001867096","role":"Director, Officer","n_filings":5,"first_seen":"2021-11-12","last_seen":"2023-08-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001346302","name":"XERIS PHARMACEUTICALS INC","url":"/issuer/0001346302","role":"Director, Officer","n_filings":5,"first_seen":"2019-03-12","last_seen":"2020-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Director","n_filings":1,"first_seen":"2018-08-27","last_seen":"2018-08-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2012-08-16","last_seen":"2014-06-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001531178","retrieved_at":"2026-08-25T19:34:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}